US Patent 7063961 Heregulin variants
Patent 7063961 was granted and assigned to Genentech on June, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Nov, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+536 characters)
Article
Patent abstract
The present invention provides heregulin variants that are capable of binding an ErbB receptor. Included in the invention are variants of human heregulins, and, in particular, variants of human heregulin-β1 having enhanced affinity for the ErbB-3 and ErbB-4 receptors. These variants include at least one amino acid substitution and can include further modifications. The invention also provides nucleic acid molecules encoding heregulin variants and related vectors, host cells, pharmaceutical compositions, and methods.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
James A. Wells0
Jennifer T. Jones0
Marcus D. Ballinger0
Mark X. Sliwkowski0
Wayne J. Fairbrother0
Date of Patent
June 20, 2006
0Patent Application Number
100827470
Date Filed
February 22, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7063961 Heregulin variants
Find more entities like US Patent 7063961 Heregulin variants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
